What it is
Immunity kadha-type products are home recipes and OTC products for seasonal immunity: boiled kadha (decoction), dried ghanvati tablets, and pre-mixed "immunity booster" powders or syrups. Recipes usually cluster giloy, tulsi, ginger, neem, black pepper, and other kitchen herbs into one daily ritual.
People talk about one kadha. Its reputation grew because cold-season boiling is common. The finished boil, tablet, or kit is a different evidence object from the ritual name.
Where you will encounter it
- Stovetop kadha during colds, flu seasons, and post-travel family routines
- OTC immunity ghanvati and "AYUSH kwath" sachets beside pharmacy vitamins
- Government-distributed immunity kits combining kadha, vati, and nasal oil during COVID-19
- Retail "immunity booster" capsules that compress the same herb cluster into one daily dose
Further detail
Ritual name
Home boil, retail ghanvati, and studied kits are not interchangeable.
Families have long boiled tulsi, ginger, and pepper for fever and cold comfort. Retail products compress that ritual into ghanvati tablets and branded sachets. Ministry advisories popularized one template. Herb order, boil time, and dose still vary. Patients carry the ritual name from the stove to the sachet to the studied kit. Research keeps separating them.
What human research has studied
Evidence attaches to a named kit or product, not to the kadha ritual as a category.
When trials exist, they usually test one named kit or add-on formulation, such as the AYURAKSHA prophylaxis bundle among Delhi police personnel or a defined guduchi-and-pippali add-on in mild COVID-19. Household ritual, pandemic retail attention, and kit-specific trial evidence share a name. They are three different things.
What the evidence does not justify
- Hearing "immunity kadha" and assuming one recipe covers the stove, the sachet, and the studied kit
- Assuming every home kadha replicates an AYURAKSHA or AYUSH advisory trial
- Stacking single-herb immunomodulatory signals across four label lines as if one product was studied
- Using immunity ritual comfort to defer vaccines, masks, or sick-day isolation when indicated
- Importing pandemic kit trial headlines as validation for every post-COVID retail immunity product
Questions worth asking
The useful first question is "Boil, tablet, or kit?"
- Fresh boiled kadha, dried ghanvati, or a branded immunity sachet?
- Which herbs and in what relative amounts? Recipe, label, or marketing image?
- Is this for cold-season comfort, fear of infection, or recovery after illness?
- What conventional prevention or treatment is this sitting alongside?
- Autoimmune disease, pregnancy, or medicines that might interact with daily bitter herbs?
Safety and interaction attention
Safety follows the recipe in hand, not the ritual name alone.
Daily multi-herb rituals stack immunomodulatory, bitter, and occasionally glucose-active ingredients at undisclosed relative doses. "Immune booster" combinations warrant caution in liver disease, autoimmune conditions, and polypharmacy. Quality variability and long-term supplemental use remain practical counseling topics.
Sources
- Nesari T, et al. AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial. Front Public Health. 2022. doi:10.3389/fpubh.2022.920126
- Kataria S, Sharma P, Ram JP, et al. A pilot clinical study of an add on Ayurvedic formulation containing Guduchi and Pippali in mild to moderate Covid-19. J Ayurveda Integr Med. 2021. doi:10.1016/j.jaim.2021.05.008
- Jamshidi N, Cohen MM. The clinical efficacy and safety of tulsi in humans: a systematic review of the literature. Evid Based Complement Alternat Med. 2017. PMC5376420
Evidence blocks last reviewed: July 2026.